Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 16, Suppl A, Pages 17A-24A
http://dx.doi.org/10.1155/2009/145071
Asthma Care in Canada

Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)

Paul K Keith,1 Caroline Koch,2 Michel Djandji,2 Jacques Bouchard,3 Eliofotisti Psaradellis,5 John S Sampalis,4,5 R Robert Schellenberg,6 and R Andrew McIvor1

1McMaster University, Hamilton, Ontario, Canada
2Merck Frosst Canada Ltd, Montreal, Canada
3Université Laval, Quebec, Canada
4McGill University, Montreal, Canada
5JSS Medical Research, Montreal, Quebec, Canada
6University of British Columbia, Vancouver, British Columbia, Canada

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Paul K Keith, Caroline Koch, Michel Djandji, et al., “Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial),” Canadian Respiratory Journal, vol. 16, no. Suppl A, pp. 17A-24A, 2009. https://doi.org/10.1155/2009/145071.